日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor Homing Nanoparticle Immunotherapy for Acute Clearance and Mitigation of T-cell Exhaustion in Humanized High-Risk Neuroblastoma

肿瘤靶向纳米颗粒免疫疗法用于人源化高危神经母细胞瘤的急性清除和T细胞耗竭缓解

Kane, Griffin I; Diaz-Infante, Miranda B; Wigglesworth, Kim; Lusi, Ellis; Brassil, Meghan; Rozen, Esteban J; Kady, Jamie; Mori, Haruka; Lukas, John; Naylor, Tiana; Dinnell, Ronnie W; Murphy, Katherine C; Alarcon, Christian Bernard B; Ruscetti, Marcus; Brehm, Michael; Shohet, Jason M; Atukorale, Prabhani U

Selective targeting of genome amplifications and repeat elements by CRISPR-Cas9 nickases to promote cancer cell death.

利用 CRISPR-Cas9 切口酶选择性靶向基因组扩增和重复元件,以促进癌细胞死亡

Hanlon Matthew B, Shohet Jason M, Wolfe Scot A

Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors

高危神经母细胞瘤诱导化疗能否在不使用粒细胞集落刺激因子(G-CSF)的情况下进行?一项关于在缺乏初始预防性造血生长因子的情况下,化疗安全性和治疗延误情况的初步研究

Whittle, Sarah B; Smith, Valeria; Silverstein, Allison; Parmeter, Margaret; Minard, Charles G; Bernhardt, M Brooke; Zage, Peter E; Venkatramani, Rajkumar; Nuchtern, Jed G; Heczey, Andras; Russell, Heidi V; Shohet, Jason M; Foster, Jennifer H

Neuroblastoma pathogenesis: deregulation of embryonic neural crest development

神经母细胞瘤发病机制:胚胎神经嵴发育失调

Tomolonis, Julie A; Agarwal, Saurabh; Shohet, Jason M

Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma

更正:MYCN在MYCN扩增型神经母细胞瘤中作为p53的直接共调节因子发挥作用

Agarwal, Saurabh; Milazzo, Giorgio; Rajapakshe, Kimal; Bernardi, Ronald; Chen, Zaowen; Eveline, Barbieri; Koster, Jan; Perini, Giovanni; Coarfa, Cristian; Shohet, Jason M

The role of histone demethylase KDM4B in Myc signaling in neuroblastoma

组蛋白去甲基化酶KDM4B在神经母细胞瘤Myc信号通路中的作用

Yang, Jun; AlTahan, Alaa M; Hu, Dongli; Wang, Yingdi; Cheng, Pei-Hsin; Morton, Christopher L; Qu, Chunxu; Nathwani, Amit C; Shohet, Jason M; Fotsis, Theodore; Koster, Jan; Versteeg, Rogier; Okada, Hitoshi; Harris, Adrian L; Davidoff, Andrew M

A p53 drug response signature identifies prognostic genes in high-risk neuroblastoma

p53药物反应特征可识别高危神经母细胞瘤的预后基因

Barbieri, Eveline; De Preter, Katleen; Capasso, Mario; Johansson, Peter; Man, Tsz-Kwong; Chen, Zaowen; Stowers, Paris; Tonini, Gian Paolo; Speleman, Frank; Shohet, Jason M

Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivo

Mdm2缺陷在体内抑制MYCN驱动的神经母细胞瘤的发生。

Chen, Zaowen; Lin, Yunfu; Barbieri, Eveline; Burlingame, Sue; Hicks, John; Ludwig, Andrew; Shohet, Jason M